"The Russian pharmaceutical market is one of the fastest growing in the world. Overall market volume in 2007 amounted to U.S.$14.3 billion in terms of retail prices, 16% more than in the previous year. This made Russia the 11th largest pharmaceutical market in the world............The market is also forecast to continue growing rapidly in 2008 and beyond.........the Russian pharmaceutical market is expected to grow over 30% in 2008 compared to 2007, reaching U.S.$18.4 billion". - DSM Group, Moscow, 21 August 2008

Biopharm Analytica offers a range of bespoke consulting and research services with regard to the bioscience and pharmaceutical sectors in Russia and the Newly Independent States. The UK-based company has undertaken market surveys for leading biotechnology multinationals and completed studies of niche technologies and markets. To discuss your detailed requirements with one of our analysts please call +44 (0)121 2702854 .

Biopharm Analytica also provides access to an independent English language online business news and information services focusing on developments in biotechnology and the pharmaceutical industry in Russia and the Newly Independent States (NIS). Drawing upon lead-edge academic research in the United Kingdom, Biopharm Analytica provides unique real-time, in-depth news coverage and analysis of the biopharmaceutical industry in the Russian Federation and the NIS. One of its key focuses is on opportunities for international companies with a strong emphasis on high-value projects which may provide opportunities for global biotech companies. Coverage is also provided of pharmaceutical and biotechnology     R & D and manufacturing projects within Russia and the NIS. Subscription to Biopharm Analytica by registered users, will allow immediate and privileged access to the information service covering major news stories impacting upon the biotechnology and pharmaceutical sectors in Russia and the NIS. A major searchable on-line news archive, providing access to Russian biopharmaceutical news reports from as early as February 1966, is available only to subscribers. It is anticipated that Biopharm Analytica's blend of news, analysis and comment will rapidly become an indispensable adjunct to those companies and analysts seeking new insight into the Russian and NIS biotechnology and pharmaceutical sectors. Credit card payments are accepted using electronic card processing facilities provided by HSBC. To discuss your subscription requirements with one of our sales staff please call +44 (0)121 2702854 .

© Biopharm Analytica Limited 2009. All Rights Reserved. This site is owned and operated by Biopharm Analytica Limited. Registered Office: Suite B, 29 Harley Street, London, W1G 9QR. Registered in England and Wales. Reg. No. 5360763. VAT Reg. No. 930 3219 57.